Arcturus Therapeutics

Arcturus Therapeutics News & Events

SEC Filing Details

Document Details

Form
Filing Date
May 22, 2020
Document Date
May 20, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Arcturus Therapeutics, Inc.
Issuer
Arcturus Therapeutics Holdings Inc.
Filer
Ultragenyx Pharmaceutical Inc.